MOXETUMOMAB PASUDOTOX-TDFK: 54 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
54
Total FAERS Reports
9 (16.7%)
Deaths Reported
20
Hospitalizations
54
As Primary/Secondary Suspect
3
Life-Threatening
Prescription
Status
FDA Application: 761104 ·
First Report: 20181112 · Latest Report: 20221012
What Are the Most Common MOXETUMOMAB PASUDOTOX-TDFK Side Effects?
#1 Most Reported
Capillary leak syndrome
13 reports (24.1%)
#2 Most Reported
Haemolytic uraemic syndrome
12 reports (22.2%)
#3 Most Reported
Weight increased
6 reports (11.1%)
All MOXETUMOMAB PASUDOTOX-TDFK Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Capillary leak syndrome | 13 | 24.1% | 3 | 8 |
| Haemolytic uraemic syndrome | 12 | 22.2% | 0 | 10 |
| Death | 6 | 11.1% | 6 | 2 |
| Weight increased | 6 | 11.1% | 1 | 2 |
Who Reports MOXETUMOMAB PASUDOTOX-TDFK Side Effects? Age & Gender Data
Gender: 24.5% female, 75.5% male. Average age: 71.0 years. Most reports from: US. View detailed demographics →
Is MOXETUMOMAB PASUDOTOX-TDFK Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 1 |
| 2019 | 13 | 1 | 2 |
| 2020 | 6 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 3 | 1 | 2 |
What Is MOXETUMOMAB PASUDOTOX-TDFK Used For?
| Indication | Reports |
|---|---|
| Hairy cell leukaemia | 37 |
| Product used for unknown indication | 6 |
Official FDA Label for MOXETUMOMAB PASUDOTOX-TDFK
Official prescribing information from the FDA-approved drug label.